Primary cutaneous amyloidosis is a chronic pruritic dermatological condition that significantly impacts the physical and mental health of patients.Currently,there is no uniform recommendation for the treatment of this disease,and the available treatments mainly include three major categories:drug therapy,physical interventions,and surgical modalities.However,the selection of treatment options depends on the severity of the patient's symptoms,individual differences,and the physician's clinical experience.As scientific inquiry progresses,novel therapeutic approaches continue to emerge.Patients are urged to maintain close collaboration with healthcare professionals throughout the treatment process,facilitating timely adjustments to the treatment plan.Comprehensive consideration of the patient's specific situation and long-term management is essential when developing an individualized treatment plan.
维普
万方数据